CellFE (Biotechnology, Health Care) — Funding, Investors & Signals 2026

CellFE

Enabling life-saving therapies with a unique platform for cell engineering

Founded 2018

Alameda, United States 31 employees Series A Total: $26.80M Biotechnology, Health Care

CellFE is a biotechnology startup with the slogan "Enabling life-saving therapies with a unique platform for cell engineering." Founded in 2018 and headquartered in the United States, CellFE has garnered significant attention in the health care industry. The company has recently received a substantial $22.00M Series A investment on 27 September 2023 from a notable group of investors including GreatPoint Ventures, Dynamk Capital, Khosla Ventures, Cota Capital, Elm Street Ventures, Embark Ventures, MERL Ventures Fund, Riverine Ventures, and EGB Capital. CellFE's focus lies in developing and manufacturing the next generation of medicines – cell therapies. The company has created a unique microfluidic platform addressing the critical issue of delivering gene-editing molecules into cells while maintaining cell viability. This technology opens doors for previously inaccessible cell therapies and expedites the commercialization of existing ones. By reducing costs, complexity, and processing time, CellFE's platform enhances the efficacy and safety of the cell engineering process, marking a significant advancement in the field of biotechnology and healthcare.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	••••••	9	•••• ••••	27 Sep 2023
Seed Round	••••••	1		16 Jan 2020
Non Equity Assistance	••••••	-		01 Sep 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

••••••

•••• ••••

27 Sep 2023

Seed Round

••••••

16 Jan 2020

Non Equity Assistance

••••••

01 Sep 2018

FAQ About CellFE

Enabling life-saving therapies with a unique platform for cell engineering

CellFE was founded in 2018.

CellFE is headquartered in Alameda, United States.

CellFE operates in the following industries: Biotechnology, Health Care.

CellFE has approximately 31 employees.

CellFE has completed 3 funding rounds, raising a total of $26.80M. The latest funding stage is Series A.

Top alternatives and competitors to CellFE include Virica Biotech, RoslinCT, Refuge Biotechnologies, iCamuno Biotherapeutics Pty Ltd, Mekonos Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

CellFE and Virica Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

CellFE

General Information

Track CellFE

Discover More

About CellFE

Funding Rounds & Investors (3)

CellFE Alternatives & Competitors

FAQ About CellFE

Don't just browse. Track.